Hybrid Catheter for Vascular Intervention
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/IL2012/000088, filed Feb 23, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,363,099 | Hybrid Catheter for Vascular Intervention In force · High confidence | Eximo Medical Ltd. | In force | High confidence | ||
| US 11,576,724 | Hybrid Catheter for Vascular Intervention In force · High confidence | Eximo Medical Ltd. | In force | High confidence | ||
| US 12,042,223 | Hybrid Catheter for Vascular Intervention In force · High confidence | Eximo Medical Ltd. | In force | High confidence | ||
| US 9,730,756 | Hybrid Catheter for Vascular Intervention In force · High confidence | Eximo Medical Ltd. | In force | High confidence | ||
| Application 18/675,359 | Hybrid Catheter for Vascular Intervention Pending Not granted | Eximo Medical Ltd. | Pending | Not granted | ||
| Application 19/015,968 | Hybrid Catheter for Vascular Intervention Pending Not granted | Eximo Medical Ltd. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Eximo Medical Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.